Latest News and Press Releases

Announces $35 Million Above Market FinancingBolsters Company’s Position with Ongoing Strategic Discussions BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII),...

BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), leading agricultural biotechnology company dedicated to improving human health with reduced nicotine...

FDA’s Proposed Rule Draws on Research That Supports Reduced Nicotine Content Cigarettes Are Less Addictive22nd Century Group’s FDA MRTP Authorized 95% Reduced Nicotine Cigarette Products Is Already...

CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century GroupIntegration of GVB Biopharma Proceeding at a Rapid Pace BUFFALO, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group,...

BUFFALO, N.Y., May 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine...

Highly Regarded for His Extensive Sales and Marketing Experience in the Tobacco Industry Expands and Further Strengthens the Company’s Team of Tobacco Industry Experts BUFFALO, N.Y., May 23, 2022 ...

Complete Hemp/Cannabis Solution from Receptor Science and Plant Genetics to Final Ingredients and CDMOConsistent, Reliable, High-Quality Cannabinoids and Cannabinoid Infused Products for...

Provides Transformational Platform to Rapidly Grow Hemp/Cannabis FranchiseTransaction Immediately Accretive and Will Double Company’s Total RevenueAdds Significant Commercial Scale to Existing...

Launched VLN® Pilot Program in Chicago with Circle K as First Retail Trade PartnerBegan VLN® Shipments to South Korea for First International LaunchFDA’s Proposed Menthol Ban Could Leave VLN® Menthol...

Exemption Would Leave 22nd Century’s VLN® Product as the Only Menthol Cigarette on the Market VLN® Menthol King Reduced Nicotine Cigarettes Are Solution To Help Current Menthol Smokers Smoke Less and...